3
Announcements
Trials
Browse
Landscape
Phase
Phase 2/3
1
Status
Recruiting
3
Completed
2
Unknown
1
Active not recruiting
1
Sponsor Class
OTHER_GOV
1
Study Type
Interventional
1
Sponsor
Cancer Type
Sarcoma
1
Conditions
Breast Neoplasms
7
Triple Negative Breast Neoplasms
2
Neoplasm Metastasis
2
Lung Neoplasms
2
Carcinoma, Hepatocellular
2
Osteosarcoma
1
Lung Metastases
1
Humoral Hypercalcemia Of Malignancy
1
Carcinoma, Non-Small-Cell Lung
1
Breast Neoplasms, Male
1
Bone Metastatic Non-small Cell Lung Cancer
1
Interventions
Methotrexate
5
Drug Therapy
5
apatinib
4
Neoadjuvant Therapy
4
Doxorubicin
3
camrelizumab
2
Ifosfamide
2
Cisplatin
2
trilaciclib
1
spartalizumab
1
palbociclib
1
isophosphamide mustard
1
irinotecan sucrosofate
1
glucarpidase
1
endostar protein
1
Zoledronic Acid
1
Vinorelbine
1
Triptorelin Pamoate
1
Trabectedin
1
Therapeutics
1
Thalidomide
1
TQ-B3525
1
Psychiatric Rehabilitation
1
Nivolumab
1
Neuropsychological Tests
1
N-(2-amino-5-fluorobenzyl)-4-(N-(pyridine-3-acrylyl)aminomethyl)benzamide
1
Microbiota
1
Metabolome
1
Magnetic Resonance Spectroscopy
1
Lithium Carbonate
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Unknown
×
Osteosarcoma
×
Zoledronic Acid
×
Clear all
NCT00691236
2011-06-23
ZOL
Tata Memorial Hospital
Phase 2/3
Unknown
60 enrolled